Concepedia

Carlos G. Rodríguez

CG

Statistics

Publications

10

Citations

1.9K

H-Index

10

Active since

2004

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Brigham and Women's Hospital

Cancer Research Institute

University of Pennsylvania

Harvard University

Carlos G. Rodríguez is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, cell signaling, and pharmacology.

Publications per year

2004–2019

10

Publications

10

<i>c-Myc</i> is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma

Andrew P. Weng, John M. Millholland, Yumi Yashiro–Ohtani et al. · Genes & Development · 2006 · 885 citations · Full text

, , +13

Mastermind critically regulates Notch-mediated lymphoid cell fate decisions

Ivan Maillard, Andrew P. Weng, Andrea C. Carpenter et al. · Blood · 2004 · 284 citations · Full text

, , +12

Tribbles homolog 2 inactivates C/EBPα and causes acute myelogenous leukemia

Karen Keeshan, Yiping He, Bas J. Wouters et al. · Cancer Cell · 2006 · 241 citations · Full text

, , +5

Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies

Patrick A. Zweidler‐McKay, Yiping He, Lanwei Xu et al. · Blood · 2005 · 191 citations · Full text

, , +12

FGF21 Analogs of Sustained Action Enabled by Orthogonal Biosynthesis Demonstrate Enhanced Antidiabetic Pharmacology in Rodents

James Mu, Jason Pinkstaff, Zhihua Li et al. · Diabetes · 2011 · 159 citations · Full text

, , +13

1–5 of 10